Report Categories
View AllRecent Articles
View All
REE REE Stock Outlook Q4 2024 EPS Tops Views
Is OP Bancorp OPBK stock outperforming the market Buying Pressure 20260418
What Whirlpool Corporation WHR does better than 90 of companies Dives 20260507
Saga SGA Stock Trade Signals Investor Concern 20260422
How BuildABear BBW competitive position shows up in earnings Q1 2026 Profit Surprises
John JHS Stock Market Structure Institutional Selling 20260420
Market Pulse Tech outperforms as consumer sector lags amid mild market pullback
Dollar Tree Shows Signs of Recovery as LongTerm Value Thesis Gains Traction
Indraprastha Gas Q4 Net Profit Declines 25 to 341 Crore Revenue Rises 6
Florida Subpoenas NFL Over Rooney Rule in Broader DEI Crackdown
Elastic NV ESTC Q1 2026 Earnings Beat Revenue NA EPS 073
DHC2042Notes DHCNI Q1 2026 Disappoints EPS 018 Below 016 Views
Knightscope KSCP Declines 647 Amid Market Weakness 20260519
Saudi Arabias Vision 2030 Spending Spree Faces Reality Check
Jim Cramer Highlights Equinix as a Strategic Data Center Investment Play
Tech and Healthcare Lead SP 500 Higher Financials Lag
Morrisons Plans to Shut Around 100 Stores Amid Rising Cost Pressures
New Fed Chair Kevin Warsh Faces Doom Loop of Debt and Inflation as Bond Market Signals Danger
Meta Plans 6065 Billion AI Spending Spree Fueling Data Center Expansion
CXDO Q1 2026 Earnings EPS Surprises 256 Above Estimates
NWPX Q1 2026 Earnings Strong Earnings Beat Drives Stock Higher
CPSS Q4 2025 Earnings EPS Misses Estimates by 105 Stock Rises
EXK Q1 2026 Earnings EPS Surges Past Estimates as Silver Production Gains Momentum
XPEL Q1 2026 Earnings Small EPS Beat Drives Stock Up 37
MGM Q1 2026 Earnings EPS Misses Estimates Amidst Operational Pressures
Intrepid Potash Inc IPI Pulls Back From Resistance Settles Near 3935
XORTX Therapeutics XRTX Gains 127 as Shares Test Key Resistance Level
Western Digital WDC Surges 834 Momentum Building Toward Key Resistance
BlackRock Capital Allocation Term Trust BCAT Posts Modest Gain Consolidates Between Key Levels
Mineralys Therapeutics MLYS Holds Steady Near Resistance as Volume Remains Muted